Control of in vivo disposition and immunogenicity of polymeric micelles by adjusting poly(sarcosine) chain lengths on surface
Source abstract
Abstract
Four kinds of A3B-type amphiphilic polydepsipeptides, (poly(sarcosine))3-b-poly(l-lactic acid) (the degree of polymerization of poly(sarcosine) are 10, 33, 55, and 85; S10 3 , S33 3 , S55 3 , and S85 3 ) were synthesized to prepare core-shell type polymeric micelles. Their in vivo dispositions and stimulations to trigger immune system to produce IgM upon multiple administrations to mice were examined. With increasing poly(sarcosine) chain lengths, the hydrophilic shell became thicker and the surface density at the most outer surface decreased on the basis of dynamic and static light scattering measurements. These two physical elements of polymeric micelles elicited opposite effects on the immune response in light of the chain length therefore to show an optimized poly(sarcosine) chain length existing between 33mer and 55mer to suppress the accelerated blood clearance phenomenon associated with polymeric micelles.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Blanco E, Shen H, Ferrari M (2015) Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33:941–95110.1038/nbt.3330 ↗
2. Brigger I, Dubernet C, Couvreur P (2012) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliver Rev 64:24–3610.1016/j.addr.2012.09.006 ↗
3. Dams ETM, Laverman P, Oyen WJG, Storm G, Scherphof GL, Van der Meer JWM, Corstens FHM, Boerman OC (2000) Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther 292:1071–107910.1016/S0022-3565(24)35391-1 ↗
4. Hara E, Makino A, Kurihara K, Yamamoto F, Ozeki E, Kimura S (2012) Pharmacokinetic change of nanoparticulate formulation "lactosome" on multiple administrations. Int Immunopharmacol 14:261–26610.1016/j.intimp.2012.07.011 ↗
5. Hara E, Ueda M, Akira M, Hara I, Ozeki E, Kimura S (2014a) Factors influencing in vivo disposition of polymeric micelles on multiple administrations. ACS Medicinal Chemistry Letters
6. Hara E, Ueda M, Kim CJ, Akira M, Hara I, Ozeki E, Kimura S (2014b) Suppressive immune response of poly(sarcosine) chains in peptide-nanosheets in contrast to polymeric micelles. Journal of Peptide Science
7. Hara E, Ueda M, Makino A, Hara I, Ozeki E, Kimura S (2014c) Factors influencing in vivo disposition of polymeric micelles on multiple administrations. ACS Med Chem Lett 5:873–87710.1021/ml500112u ↗
8. Ishida T, Harada M, Wang XY, Ichihara M, Irimura K, Kiwada H (2005) Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. J Control Release 105:305–31710.1016/j.jconrel.2005.04.003 ↗
9. Ishida T, Maeda R, Ichihara M, Irimura K, Kiwada H (2003a) Accelerated clearance of PEGylated liposomes in rats after repeated injections. J Control Release 88:35–4210.1016/S0168-3659(02)00462-5 ↗
10. Ishida T, Maeda R, Masuda K, Ichihara M, Kiwada H (2003b) The accelerated clearance effect on multiple injection of sterically stabilized liposomes in mice and rats: species difference. Journal of Liposome Research 13:67–67
11. Ishida T, Masuda K, Ichikawa T, Ichihara M, Irimura K, Kiwada H (2003c) Accelerated clearance of a second injection of PEGylated liposomes in mice. Int J Pharm 255:167–17410.1016/S0378-5173(03)00085-1 ↗
12. Ishida T, Wang X, Shimizu T, Nawata K, Kiwada H (2007) PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. J Control Release 122:349–35510.1016/j.jconrel.2007.05.015 ↗
13. Ishihara T, Maeda T, Sakamoto H, Takasaki N, Shigyo M, Ishida T, Kiwada H, Mizushima Y, Mizushima T (2010) Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers. Biomacromolecules 11:2700–270610.1021/bm100754e ↗
14. Kalyanasundaram K, Thomas JK (1977) Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems. J Am Chem Soc 99:2039–204410.1021/ja00449a004 ↗
15. Kim CJ, Hara E, Shimizu A, Sugai M, Kimura S (2015) Activation of B1a cells in peritoneal cavity by T cell-independent antigen expressed on polymeric micelle. J Pharm Sci-Us 104:1839–184710.1002/jps.24397 ↗
16. Koide H, Asai T, Hatanaka K, Urakami T, Ishii T, Kenjo E, Nishihara M, Yokoyama M, Ishida T, Kiwada H, Oku N (2008) Particle size-dependent triggering of accelerated blood clearance phenomenon. Int J Pharm 362:197–20010.1016/j.ijpharm.2008.06.004 ↗
17. Kurihara K, Ueda M, Hara I, Hara E, Sano K, Makino A, Ozeki E, Yamamoto F, Saji H, Togashi K, Kimura S (2016) Inflammation-induced synergetic enhancement of nanoparticle treatments with DOXIL (R) and Y-90-lactosome for orthotopic mammary tumor. J Nanopart Res 18
18. Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. In Advances in Enzyme Regulation, Vol 41, Weber G (ed), Vol. 41, pp 189–207. Oxford: Pergamon-Elsevier Science Ltd10.1016/S0065-2571(00)00013-3 ↗
19. Maeda H (2010) Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 21:797–80210.1021/bc100070g ↗
20. Makino A, Kizaka-Kondoh S, Yamahara R, Hara I, Kanzaki T, Ozeki E, Hiraoka M, Kimura S (2009) Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide. Biomaterials 30:5156–516010.1016/j.biomaterials.2009.05.046 ↗
21. Shiraishi K, Hamano M, Ma HL, Kawano K, Maitani Y, Aoshi T, Ishii KJ, Yokoyama M (2013) Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. J Control Release 165:183–19010.1016/j.jconrel.2012.11.016 ↗
22. Suzuki T, Ichihara M, Hyodo K, Yamamoto E, Ishida T, Kiwada H, Ishihara H, Kikuchi H (2012) Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs. Int J Pharm 436:636–64310.1016/j.ijpharm.2012.07.049 ↗
23. Suzuki T, Ichihara M, Hyodo K, Yamamoto E, Ishida T, Kiwada H, Kikuchi H, Ishihara H (2014) Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin. Int J Pharm 476:205–21210.1016/j.ijpharm.2014.09.047 ↗
24. Tsujii Y, Ohno K, Yamamoto S, Goto A, Fukuda T (2006) Structure and properties of high-density polymer brushes prepared by surface-initiated living radical polymerization. Adv Polym Sci 197:1–4510.1007/12_063 ↗
25. Wang AZ, Langer R, Farokhzad OC (2012) Nanoparticle delivery of cancer drugs. Annu Rev Med 63:185–19810.1146/annurev-med-040210-162544 ↗
26. Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, Chan WCW (2016) Analysis of nanoparticle delivery to tumours. Nat Rev Mater 110.1038/natrevmats.2016.14 ↗
27. Xie J, Lee S, Chen XY (2010) Nanoparticle-based theranostic agents. Adv Drug Deliver Rev 62:1064–107910.1016/j.addr.2010.07.009 ↗